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Sudden cardiac death refers to unexpected death attributable
to a cardiac cause occurring within 1 h of the onset of symp-
toms (NICE, 2006). It often results from cardiac arrhythmias
and is a major worldwide cause of morbidity and mortality.
Arrhythmias account for 180,000 to 250,000 deaths per year in
the United States and ∼70,000 deaths per year in the United
Kingdom (NICE, 2006; Chugh et al., 2008). These commonly
present as ventricular fibrillation often preceded by ventricu-
lar tachycardia (Turakhia and Tseng, 2007). Cardiac arrhythmias
most frequently result from underlying ischaemic heart disease
(Behr et al., 2003). However, ∼4% may arise from ion channel
abnormalities (Tung et al., 1994; Martin et al., 2012) with their
own implications for management (Martin et al., 2011). In all
events, cardiac arrhythmias follow disruption of the normal cell
excitation and recovery sequence propagating through succes-
sive cardiac regions. A sequence of reviews and original articles
in Frontiers in Cardiac Electrophysiology together survey genetic,
biophysical, physiological and modeling studies bearing upon
mechanisms of and possible translational implications for ven-
tricular arrhythmia and sudden cardiac death, referring to other
arrhythmic situations, particularly atrial fibrillation, where these
throw light upon fundamental mechanisms.
Kapur and Macrae (2013) review developmental events regu-
lating appearance of molecules and structures underlying normal
automaticity and conduction responsible for atrial rhythm, pro-
viding a necessary background for normal ventricular activation.
Jagu et al. (2013) then outline and illustrate outcomes of genetic
studies of biochemical processes underlying relationships between
genetic background and protein expression whose alterations lead
to arrhythmic tendency. Ion channel expression depends upon
a sequence of processes beginning with DNA transcription into
mRNA and its regulation by promoter sites. Persistence of the
resulting mRNA then depends upon its stability and the pres-
ence or absence of mRNA splicing. Translation from mRNA into
protein is potentially regulated by microRNAs and alternative
translation phenomena. Finally, expression of synthesized protein
depends upon its assembly, post-translational modification and
trafficking to its normal membrane site.
Nielsen et al. (2013) further explore uncertainties in rela-
tionships between genetic change and their functional consequences
specifically for Brugada Syndrome (BrS). This condition is asso-
ciated with hundreds of variants in 17 genes, most commonly
with SCN5Amutations implicating cardiac voltage-gated sodium
channels. However, ∼70% of BrS cases cannot currently be
explained genetically. Clarification of these relationships would
enhance genetic risk stratification taking advantage of multi-gene
Next Generation Sequencing. However, Gütter et al. (2013) throw
biophysical light on uncertainties in the relationship between
genetic and functional properties: voltage-clamp investigations
revealed that only one out of three mutant channels associ-
ated with clinical long QT syndrome type 3 (LQT3) and three
out of six mutant channels associated with BrS showed func-
tional abnormalities in a series of N-terminal, human hNav1.5,
mutations.
Nevertheless Nielsen et al. (2013) associate more severe BrS
disease phenotypes with large as opposed to small reductions
in INa, whose most obvious biophysical effect is to reduce
action potential conduction velocity, producing potentially pro-
arrhythmic re-entrant substrate. King et al. (2013) review factors
affecting cardiac conduction velocity. The underlying local cir-
cuit current flows between myocytes depend upon not only on
fast Na+ current, but also axial resistance and cellular excitability.
These could alter with impaired Na+ channel and gap junc-
tion function, and altered tissue geometry following fibrotic
change accompanying pathophysiological processes. Such sub-
stratemay accompany arrhythmic situations particularly with the
triggering events typically associated with disrupted Ca2+ home-
ostasis exemplified by the altered sarcoplasmic reticular Ca2+
release through RyR2-Ca2+ release channels in catecholaminergic
polymorphic ventricular tachycardia. Zhang et al. (2013) sum-
marize recent studies associating RyR2 abnormalities with atrial
in addition to ventricular arrhythmias. They further point out
that homozygotic RyR2-P2328S hearts show reduced conduction
velocities potentially generating arrhythmic substrate, in addition
to delayed afterdepolarization and ectopic action potential firing.
Computational studies permit biophysical information to be
compiled into theoretical reconstructions of in vivo physiologi-
cal changes resulting from a primary loss or gain of function.
Thus, carbon monoxide (CO) is produced by a number of
different mammalian tissues and exerts significant cardiovascu-
lar effects. Computational studies (Trenor et al., 2013) relate
known changes in CO-induced alterations in ventricular slowly-
inactivating ranolazine-sensitive late Na+, and Ca2+, channel,
activity, to potentially pro-arrhythmic after-depolarization-like
rhythm disturbances illustrating important elements of their
underlying causes. Computational studies also illuminate in vivo
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physiological outcomes even where primary experimental systems
are not available. Adeniran et al. (2013) apply these to the rel-
atively rare, but well-defined clinical short QT syndrome, asso-
ciated with accelerated ventricular repolarization, arrhythmias
and sudden cardiac death. Few experimental SQT1 and SQT3
models, involving altered K+ or Ca2+ channel function are cur-
rently available. Nevertheless, application of the ten Tusscher and
Panfilov (TP) human ventricular single cell model allowed in sil-
ico exploration of the consequences of this condition for Ca2+
release and mechanical output. Combined with cable theory, this
further yielded whole organ functional reconstructions. This pro-
vided testable predictions implicating stretch-activated current in
contractile function. Finally, an original contribution by Finlay
et al. (2013) then successfully apply a modeling approach based
on one-dimensional cable theory to describe human restitution
dynamics incorporating both conduction velocity restitution and
action potential restitution, for the first time in man.
Finally, discussions of possible clinical translational develop-
ments begin with problems and methodologies associated with
diagnosis of sudden cardiac death risk. Vyas and Lambiase (2013)
evaluate currently available screening strategies for sudden cardiac
death risk in sudden arrhythmic death syndrome families, look-
ing forward to roles for molecular autopsy and genetic testing,
and potential future applications of stem cell-based diagnos-
tic strategies. The first of two preliminary clinical studies report
findings relating to sphingolipid levels as novel markers for
early detection of human myocardial ischaemic injury predis-
posing to malignant ventricular arrhythmias (Egom et al., 2013).
A report in chronic kidney disease patients, in which both early
repolarization and sudden cardiac death are common, neverthe-
less did not associate early repolarization with increased 1-year
mortality or entry onto dialysis programs (Hajhosseiny et al.,
2013).
This collection of articles thus overviews current knowledge
bearing on experimental studies of sudden cardiac death and
its associated arrhythmias, and possible translational insights
concerning clinical prevention and management.
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